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 Background: Immunosuppression, denervation of biliary tract, and presence of biliary strictures favor colonization of bile 
with microorganisms after liver transplantation. Little is known about spectrum and antibiotic susceptibility of 
this colonization.
 Material/Methods: Bile and feces were collected prospectively from 38 patients who underwent endoscopic retrograde cholangio-
pancreaticography after liver transplantation. Samples were analyzed for colonization and antibiotic susceptibility.
 Results: From the 38 tested bile samples, 86.6% tested positive. Of those, 26 (78.8%) were polymicrobial. Of isolated 
bile samples, 52 (64.2%) were gram-positive, 22.2% were gram-negative, and 13.6% revealed Candida albicans. 
Most detectable gram-positive bacteria were Enterococcus faecium. Most detectable gram-negative bacteria 
were E. coli and Klebsiella pneumonia. Our analyses revealed high resistance rates of the isolates. Only 55.6% 
of isolates were sensitive to ciprofloxacin, 54% were sensitive to piperacillin/tazobactam, and 60.3% were sen-
sitive to imipenem. High susceptibility rates were found for linezolid and vancomycin (72.9% and 72.6%, re-
spectively). We found a high correlation between microorganisms found in bile and those isolated from stool.
 Conclusions: Bile of liver transplant recipients is frequently colonized with microorganisms. The starting point of this coloni-
zation is usually the intestine. Systematic analysis of bile colonization during endoscopic interventions on bili-
ary tracts of liver transplant recipients might help to select effective prophylactic antibiotic regimes as well as 
to facilitate the choice of suitable antimicrobial therapy in case of septic complications.
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Background
Biliary complications after liver transplantation (LT) are com-
mon and remain a major source of morbidity; thus, they signif-
icantly influence patient and organ survival [1]. In recent years, 
endoscopic retrograde cholangiopancreatography (ERCP) has 
superseded surgery as the gold standard in management of 
bile duct complications after LT [2]. However, ERCP still is an 
invasive tool and may have serious complications such as pan-
creatitis, perforation, bleeding, and septic complications [2,3].
Infectious complications are among the most common causes of 
death after ERCP [4,5]. Septic complications after ERCP include 
bacteremia, sepsis, ascending cholangitis, and liver abscess. A 
potential focus for infectious complications may be bactibilia.
Although bile is sterile in healthy individuals [6,7], bactibilia 
is frequently found in patients after LT. Additional risk factors 
for colonization of bile include the presence of foreign bodies 
such as stones and stents [8,9].
Immunosuppression and occurrence of biliary strictures af-
ter LT favor colonization of bile with microorganisms. Little is 
known about the clinical relevance of this colonization, but pre-
liminary data show that colonization of bile with bacteria and 
fungi is associated with development of septic complications 
after endoscopic interventions on the bile duct [10]. However, 
recent antibiotic prophylaxis of ERCP-induced septic compli-
cations is based on recommendations in the non-transplant 
setting. Furthermore, there are currently no guidelines for the 
treatment of septic complications after endoscopic biliary in-
terventions in liver transplant recipients. This is especially im-
portant because most of these patients have had multiple an-
tibiotic therapies in the course of their liver disease.
Therefore, the aim of this study was to evaluate microbiological 
spectrum and antibiotic resistance of specimens found in bile 
of liver-transplanted individuals who underwent ERCP, in order 
to investigate the clinical efficacy of antibiotics administered to 
prevent infectious complications. Since there is evidence that 
enteric flora represents a reservoir for ascending cholangitis and 
further infectious diseases, particularly after LT [11,12], we addi-
tionally analyzed enteric flora and the correlation between iso-
lates found in bile and stool cultures in our patient population.
Material and Methods
This prospective study was carried out between May 2011 and 
September 2013 at the University Hospital of Münster. Thirty-
eight patients (25 (65.8%) were male and 13 (34.2%) were fe-
male, mean age was 52.2±11.4 years) were enrolled into the 
study after LT. Table 1 shows patients’ characteristics and 
endoscopic findings. All patients gave written informed con-
sent and treatment was performed in adherence to the guide-
lines of the Declaration of Helsinki. The trial was approved by 
the local ethics committee. Indications for ERCP were increas-
ing liver and cholestatic parameters with or without an intra- 
or extra-hepatic biliary dilatation seen on imaging. All patients 
were treated with at least 1 immunosuppressant. Twenty-
seven (71.1%) were on calcineurin-inhibitor-based immuno-
suppression (57.9% on tacrolimus and 13.1% on ciclosporin), 
and eight (21.1%) were on m-TOR-based immunosuppression 
(13.2% everolimus and 7.9% sirolimus). Two patients (5.3%) 
were maintained on tacrolimus in combination with everolim-
us and 1 patient (2.6%) received mycophenolate mofetil only.
Bile was collected either via percutaneous biliary drainage (PTC) 
in nine patients and during ERCP in 29 patients. Endoscopic 
retrograde cholangiopancreaticography was performed using 
a therapeutic duodenoscope (TJF-180V, Olympus Corp., Tokyo, 
Japan). The bile duct was accessed with wire-guided cannulation 
N 38
Male  25 (65.8%)
Female  13 (34.2%)
Age, yr, mean ±SD 52.2±11.4
Etiology of liver disease
 Alcohol 15
 HCC 8
 Hepatitis B/C virus 5
 Cholestatic liver diseases 5
 Other 5
  Time from transplant to 
ERCP, months
25.6 (range 0.3–164.2)
Endoscopic findings
 AS  13 (44.8%)
 NAS  4 (13.8%)
 Biliary leakage  4 (13.8%)
 Stones  1 (3.4%)
 ITBL  1 (3.4%)
 Biliary cast  1 (3.4%)
 Non  5 (17.2%)
Table 1.  Demographic and clinical characteristics and endo-
scopic findings in the 38 LT recipients.
HCC – hepatocellular carcinoma; AS – anastomotic stricture; 
NAS – non-anastomotic stricture, ITBL – ischemic type biliary 
lesion.
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using a sterile sphincterotome (0.035 inch, THSF-35-480, Cook 
Medical INC.; Tri-Tome, TRI 20, Cook Medical, Inc.). Bile was as-
pirated immediately after cannulation of the bile duct before 
contrast material was administered. Approximately 2–5 mL of 
bile were collected and immediately submitted to microbio-
logical laboratory analysis in a sterile syringe. Stool samples 
were also collected from each patient and submitted to the 
microbiological laboratory in the same way.
Bile was streaked out on Columbia blood agar, McConkey agar, 
Kimmig agar, and boiled blood agar under increased CO2 atmo-
sphere (5–10%) to detect aerobic growth. To detect anaerobic 
microorganisms, we used Schaedler agar and Thioglycolate-
Bouillon. All samples were incubated at 35° to 37°C. Plates 
were examined after 24 h and 48 h. For identification, we 
used matrix-assisted laser desorption ionization time-of-flight 
mass spectrometry (MALDI-TOF MS, microflex©, Bruker Daltonik 
GmbH, Bremen). Susceptibility testing was performed by Vitek 
2 (bioMerieux©, Nürtingen, Germany).
If bile specimens showed any growth of microorganisms, stool 
specimens were investigated in the same way. Only microor-
ganisms previously found in bile cultures were identified and 
tested for antibiotic susceptibility.
Antibiotic prophylaxis
Antibiotics were routinely administered prophylactically in all 
patients who received ERCP; 18 out of 29 patients (62.1%) re-
ceived ciprofloxacin (2×750 mg daily), 2 patients (6.9%) received 
imipenem (3×500 mg daily), and nine patients (31.0%) received 
piperacillin (3×4 g daily) administered in combination with tazo-
bactam (3×0.5 mg daily). Administration of antimicrobial pro-
phylaxis was started 2 hours before ERCP and was continued 
for 3 days after intervention. The selection of antibiotics for pro-
phylactic use was made by the responsible attending physician.
Statistical analysis
Statistical analysis was performed using SPSS Statistics 20 for 
Windows. Data are presented as mean ± standard deviation 
and percentages for categorical variables. Comparison of data 
was performed using Fisher’s exact test. A 2-sided p<0.05 was 
considered significant.
Results
Endoscopic findings of the 29 patients who received ERCP were 
anastomotic strictures in 13 cases (44.8%), non-anastomot-
ic strictures in 4 (13.8%), biliary leakage in 4 (13.8%), stones 
in 1 (3.4%), biliary cast in 1 (3.4%), and normal biliary tree in 
5 patients (17.2%).
From the 38 bile samples obtained, 33 (86.8%) bile cultures 
tested positive and 5 (13.2%) showed no microbial growth. 
Seven (21.2%) of the positive bile cultures showed only 1 iso-
late and 26 (78.8%) were polymicrobial. A total of 81 microor-
ganisms were isolated; 52 (64.2%) gram-positive, 18 (22.2%) 
gram-negative, and 11 (13.6%) Candida albicans. Most com-
mon gram-positive isolates were Enterococcus faecium (13.6%), 
Enterococcus faecalis (12.3%), Staphylococcus haemolyticus 
(7.4%), and Staphylococcus epidermidis (7.4%). Most com-
mon gram-negative isolates were Escherichia coli (4.9%) and 
Klebsiella pneumoniae (4.9%). There was no difference con-
cerning the microbial spectrum and their resistogram between 
the isolates from bile collected during ERCP and during PTC. 
Groups of microorganisms found in bile are shown in Figure 1.
Three patients developed fever in the time between 2 days be-
fore and 10 days after ERCP. In all 3, isolates from blood were 
the same as those found in bile.
According to our results, the only risk factor for bile coloniza-
tion was a previous endoscopic sphincterotomy, which that 
was pre-existent in 21 patients (55.3%) (p=0.012). Table 2 
shows isolates from bile in patients with and without pre-ex-
isting endoscopic sphincterotomy. We found no statistical cor-
relation between endoscopic findings and/or stent placement 
and the colonization of bile (p>0.05).
Antibiotic susceptibility in bile
Bacterial isolates were tested for antibiotics typically used for 
prophylaxis of septic complications after ERCP (ciprofloxacin, 
imipenem, and piperacillin/tazobactam) and also for vanco-
mycin and linezolid. Susceptibility to ciprofloxacin was found 
Others; 15.7
Enterococci; 30.8
Staphylococci; 14.8
Streptococci; 12.3
Klebsiela; 7.4
E. coli; 4.9
Candida; 13.6
Figure 1. Groups of microorganisms found in bile [%].
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in 55.6% of cases, to piperacillin/tazobactam in 54.0%, to 
imipenem in 60.3%, to vancomycin in 72.6%, and to linezolid 
in 72.9%. All bacteria with imipenem resistance were gram-
negative. One vancomycin-resistant enterococcus (VRE) and 
1 bacterium with extended-spectrum beta-lactamase (ESBL) 
were isolated.
Only 70.8% of isolates collected during ERCP were sensitive to 
given antibiotic prophylaxis. Had the patients received either 
linezolid or vancomycin additionally, an additional 25% of bac-
teria (95.8% in total) would have been covered by the anti-
biotic therapy.
Of the tested bacteria, 33.3% were resistant to all 3 antibi-
otics used (ciprofloxacin, imipenem, and piperacillin/combac-
tam) and 41.2% were sensitive to all 3 antibiotics. An add-on 
administration of linezolid or vancomycin would have covered 
a total of 90.5% of all resistant bacteria.
Isolates Total Patients with EST Patients without EST
Enterococcus faecium 11 8 3
Enterococcus faecalis 10 9 1
Enterococcus avium 4 3 1
Staphylococcus haemolyticus 6 4 2
Staphylococcus epidermidis 6 2 4
Escherichia coli 4 4 0
Klebsiella pneumoniae 4 3 1
Klebsiella oxytoca 2 2 0
Streptococcus parasanguinis 2 0 2
Streptococcus salivarius 2 0 2
Streptococcus anginosus 2 2 0
Streptococcus sanguinis 1 1 0
Streptococcus oralis 1 0 1
Streptococcus pneumoniae 1 0 1
Streptococcus viridans 1 0 1
Stenotrophomonas maltophilia 2 0 2
Hafnia alvei 1 1 0
Bacillus spp. 1 0 1
Lactobacillus gasseri 1 1 0
Lactobacillus rhamnosus 1 0 1
Enterobacter cloacae 1 1 0
Pseudomonas aeruginosa 1 0 1
Pseudomonas stutzeri 1 0 1
Corynebacterium jeikeium 1 1 0
Micrococcus luteus 1 0 1
Kocuria palustris 1 0 1
Proteus mirabilis 1 1 0
Candida 11 10 1
Total 81 53 28
Table 2. Microorganisms isolated from bile in patients with and without pre-existing EST.
EST – endoscopic sphincterotomy.
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Stool
A total of 43 microorganisms were isolated from feces (Table 4). 
Twenty-six (60.5%) were gram-positive, 11 (25.5%) were gram-
negative strains, and 6 (14.0%) were Candida species. The 
most common bacteria were Enterococcus faecium (32.6%), 
Enterococcus faecalis (16.3%), and Escherichia coli (11.6%).
Comparison between bile cultures and stool cultures
In 24.1% of patients, all microorganisms found in bile could also 
been found in stool. In 75.9% of cases, at least 1 microorganism 
found in bile was also found in stool and in 24.1% of patients, 
microorganisms found in bile could not been found in stool.
Discussion
Diagnosis and therapy of biliary complications after LT is a do-
main of ERCP. However, ERCP is an invasive procedure and can 
lead to several severe complications, especially if further in-
terventions (such as sphincterotomy, balloon dilatation, and/
or endoscopic drain placement) are required. Some of these 
dreaded complications are septic in nature [12–14]. In our 
study, we analyzed the spectrum of isolates found in bile of 
liver transplant recipients during ERCP and tested their sensi-
tivity to given antibiotic prophylaxis.
Septic complications such as cholangitis are dreaded after ERCP 
in liver transplant population. A starting point for the bile colo-
nization is the intestine. From there, ascending microorganisms 
can lead to septic complications, especially in case of biliary 
Antibiotics
Sensitive isolates Intermediate isolates Resistant isolates
Number % Number % Number %
Ciprofloxacin 35 55.6 1 1.6 27 42.9
Piperacillin/tazobactam 34 54.0 4 6.3 25 39.7
Imipenem 38 60.3 1 1.6 24 38.1
Sulfamethoxazole/trimethoprim 15 23.8 1 1.6 47 74.6
Cefotaxime 22 34.9 1 1.6 40 63.5
Erythromycin 13 21.0 4 6.5 45 72.6
Linezolid 43 72.9 – -– 16 27.1
Vancomycin 45 72.6 – – 17 27.4
Table 3. Antibiotic resistance of microorganisms.
Isolates Number %
Enterococcus faecium 14 32.6
Enterococcus faecalis 7 16.3
Escherichia coli 5 11.6
Candida 6 14.0
Klebsiella pneumoniae 3 7.0
Enterococcus avium 3 7.0
Enterobacter cloacae 1 2.3
Pseudomonas aeruginosa 1 2.3
Staphylococcus aureus 1 2.3
Staphylococcus haemolyticus 1 2.3
Hafnia alvei 1 2.3
Total 43
Table 4. Microorganisms isolated from stool.
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obstruction and/or immunosuppression [15–17]. Negm et al. 
identified liver transplantation as a risk factor for biliary colo-
nization with microorganisms. In the same study, Negm et al. 
showed the clinical relevance of collected bile cultures dur-
ing ERCP in case of complicating cholangitis [8]. Furthermore, 
Barkholt et al. showed in 1997 that intestinal flora represents 
a reservoir for ascending cholangitis and other infections, es-
pecially after liver transplantation [11].
Our results show a completely different spectrum of microor-
ganisms found in bile of liver transplant recipients in compari-
son with that found in bile of immunocompetent non-transplant 
individuals. In our study, in 64.2% of cases we found gram-pos-
itive bacteria, in 22.2% gram-negative bacteria, and in 13.5% 
Candida. Most common isolates were Enterococcus species, 
whereas, in the non-transplant setting, more gram-negative 
bacteria, especially E. coli and klebsiella, are found [18–21]. Our 
results confirm former studies that showed a shift in microbial 
spectrum in bile of immunosuppressed patients after LT towards 
gram-positive bacteria with a markedly increased incidence of 
Enterococci [8–10]. Those findings emphasize the relevance of 
analysis of bile isolates in liver transplant recipients with re-
gard to the spectrum and resistogram to select an effective an-
tibiotic prophylaxis for these patients and also to treat poten-
tial septic complications after ERCP in liver transplant patients.
The use of only vancomycin or linezolid would have covered 
nearly 73% of the detected bacteria. The addition of vancomy-
cin or linezolid to the originally administered antibiotics would 
have covered more than 95% of isolates. This is due to the 
above-mentioned increased incidence of gram-positive bacteria 
in the bile of liver transplant patients, especially of Enterococci.
In 2006 Millonig et al. found resistance rates to ciprofloxa-
cin, piperacillin / tazobactam, and imipenem of only 19–32% 
of bacteria isolated from bile of liver transplant recipients [9]. 
These resistance rates are lower than those demonstrated in 
our study. A possible explanation for that is the global increase 
of acquired antimicrobial resistance among bacteria [22,23].
In our study we found a high correlation between microorgan-
isms found in bile and those isolated from stool. This finding, 
and identifying sphincterotomy as a risk factor for bile colo-
nization, confirm the results of former studies that identify 
the intestinum as a starting point for ascending colonization 
of bile and thus for septic complications after ERCP such as 
cholangitis and sepsis [15–17]. The spectrum of the intesti-
nal flora is based on a continuous interplay between the im-
mune system and microorganisms [24]. Through the influence 
of immunosuppression after LT, this balance between immune 
system and gut flora may be disrupted, which can lead to an 
increased tolerance of gram-positive bacteria, especially en-
terococci, by the impaired immune system of the gut.
Interestingly, in all patients who developed signs of septice-
mia with the evidence of positive blood cultures, there was 
a match between isolates from blood and those from bile.
Conclusions
In conclusion, bile of liver transplant recipients is predom-
inantly colonized with microorganisms. This colonization is 
most likely a consequence of ascension of the microorgan-
isms from the gut. Therefore, the monitoring of bile during 
endoscopic intervention in the biliary tract of liver transplant 
patients could help to select effective prophylactic antibiot-
ic regimes as well as to facilitate the choice of suitable an-
timicrobial therapy in case of cholangitis and sepsis. Gram-
positive bacteria, especially Enterococci, seem to be frequent 
in bile of liver transplant recipients. Therefore, in case of 
septic complications after ERCP, empiric antibiotic therapy 
should include vancomycin or linezolid. Further prospective, 
large-scale, randomized trials are warranted to confirm our 
findings and to modulate the generally recommended anti-
biotic prophylaxis in case of needed endoscopic biliary in-
terventions after LT.
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